论文部分内容阅读
目的观察康复新液治疗手足口病的疗效。方法 160例手足口病患儿随机分为两组,均予以利巴韦林抗病毒,对症治疗。对照组80例予0.9%氯化钠外用,实验组80例予以康复新液外用。结果两组在总有效率上无明显差别(P>0.05);但是实验组显效率、临床症状消退时间均明显优于对照组(P<0.05)。结论康复新液辅助治疗小儿手足口病疗效确切,未见明显不良反应。
Objective To observe the curative effect of Kangfuxin solution on hand-foot-mouth disease. Methods 160 cases of hand-foot-mouth disease were randomly divided into two groups, all given ribavirin antiviral therapy for symptomatic treatment. 80 cases in the control group were given 0.9% sodium chloride for external use, and 80 cases in the experimental group were treated with rehabilitation liquid. Results There was no significant difference between the two groups in the total effective rate (P> 0.05). However, the effective rate of the experimental group and the regression time of clinical symptoms were significantly better than those of the control group (P <0.05). Conclusion Kangfuxin solution is effective in treating hand-foot-mouth disease in children with no apparent adverse reactions.